Quanta Therapeutics has filed a notice of an exempt offering of securities to raise $54,999,988.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Quanta Therapeutics is raising $54,999,988.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Perry Nisen played a key role…